Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Muscular Dystrophy Association
< Previous
1
2
Next >
Muscular Dystrophy Association Applauds Expanded US FDA Approval of ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy Patients Ages 4 and Above
June 20, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association’s Impact to End ALS Continues with Fourth Annual Lou Gehrig Day at Major League Baseball Games
May 21, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
MDA's Pinup & Roundup Campaigns Kick Off Across the Nation to Support Summer Camp for Kids and Young Adults Living with Neuromuscular Diseases
May 20, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates Historic Advancements in Accessible Air Travel as Congress Passes FAA Reauthorization
May 15, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answering the Call’
April 29, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Launches ‘Access The Vote’ Campaign to Amplify Rights of Accessible Voting
April 23, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce Collaborative Research Grant Using Novel Gene Editing Technology to Address Root Cause of Friedreich’s Ataxia Disease
April 17, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide for Muscular Dystrophy Association
April 10, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Burn Boot Camp and Muscular Dystrophy Association Team Up for 8th Annual 'Be Their Muscle' Philanthropic Event
March 25, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association’s Funding of Foundational Research Leads to New FDA Approved Treatment Duvyzat (givinostat) for Duchenne Muscular Dystrophy
March 21, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
NFL Running Back Nyheim Hines Supports Nation's Largest St. Patrick’s Day Fundraising Campaign to Benefit Muscular Dystrophy Association
March 13, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Applauds Landmark Proposal on Accessible Air Travel at The White House
February 29, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference
February 15, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces Seven Recipient Organizations of Advocacy Collaboration Grants
February 01, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces Recipient of 2024 MDA Legacy Award for Achievement in Research, is Jeffrey Chamberlain, Ph.D., Leading Professor in Gene Therapy
January 30, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Opens Registration for Campers and Volunteers for MDA Summer Camp 2024 to be Held at Locations Nationwide
January 22, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces 2024 National Ambassador Ira Walker
January 08, 2024
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces Acosta Group’s Historic $100 Million Fundraising Milestone
December 21, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide
November 01, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces Collaboration with Mitsubishi Tanabe Pharma America for Remote Digital Technology Research Study for Amyotrophic Lateral Sclerosis (ALS)
October 30, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA
October 26, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients
October 18, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates FDA Approval of Amicus Therapeutics’ Pombiliti + Opfolda for Treatment of Pompe Disease
September 28, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Announces Research Grants Totaling $8.4 Million
September 13, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Kicks Off 30 Days of Strength Campaign for National Muscular Dystrophy Awareness Month in September
August 28, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
August 21, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Registration Now Open for 2024 MDA Clinical & Scientific Conference, to Showcase Cutting Edge Research Advancements and Clinical Achievements in Neuromuscular Disease
August 09, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates FDA Approval of UCB’s RYSTIGGO for the Treatment of Generalized Myasthenia Gravis
June 27, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates FDA Approval of Sarepta Therapeutics’ ELEVIDYS for Treatment of Duchenne Muscular Dystrophy
June 22, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
Muscular Dystrophy Association Celebrates FDA Approval of argenx’s Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia Gravis
June 20, 2023
From
Muscular Dystrophy Association
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.